Neogen reported $57.41M in Gross Profit on Sales for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Agilent A:US $ 861M 49M
Atrion ATRI:US 17.38M 414K
Avanos Medical Inc AVNS:US $ 107.2M 10.3M
Bio Rad Laboratories BIO:US $ 403.56M 2.66M
Cerus CERS:US $ 24.94M 5.67M
Danaher DHR:US $ 4705M 238M
Idexx Laboratories IDXX:US $ 498.75M 42.33M
Illumina ILMN:US $ 815M 2M
Integra Lifesciences IART:US $ 238.6M 16.25M
Meridian Bioscience VIVO:US $ 68.48M 19.32M
Nanostring Technologies NSTG:US $ 16.3M 6.11M
Orasure Technologies OSUR:US $ 24.27M 2.86M
Pacific Biosciences Of California PACB:US $ 14.16M 2.61M
Quidel QDEL:US $ 739.96M 250.62M
Sientra SIEN:US 12.84M 518K
Staar Surgical STAA:US $ 49.26M 4.27M
Surmodics SRDX:US $ 21M 2.49M
Thermo Fisher Scientific TMO:US $ 5464M 210M
Utah Medical Products UTMD:US 8.07M 1.13M
Zoetis ZTS:US $ 1421M 50M